Endocrine response and resistance in breast cancer: a role for the transcription factor Fos

This publication has 34 references indexed in Scilit:

• Estrogen-Induced c-fos Protooncogene Expression in MCF-7 Human Breast Cancer Cells: Role of Estrogen Receptor Sp1 Complex Formation*
  Endocrinology, 1998
• Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer
  International Journal of Cancer, 1997
• Immunocytochemical localization of fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy
  International Journal of Cancer, 1995
• Heat‐Induced bFGF gene expression in the absence of heat shock element correlates with enhanced AP‐1 binding activity
  Journal of Cellular Physiology, 1995
• Oncogene Protein Co-Expression Value of Ha-ras, c-myc, c-fos, and p53 as Prognostic Discriminants for Breast Carcinoma
  Annals of Surgery, 1995
• Prolonged treatment of breast cancer cells with antiestrogens increases the activating protein-1-mediated response: involvement of the estrogen receptor.
  Endocrinology, 1995
• Measurement of S-phase fraction and ploidy in sequential fine-needle aspirates from primary human breast tumours treated with tamoxifen
  British Journal of Cancer, 1994
• Cell Cycle Kinetic Effects of Tamoxifen on Human Breast Cancer Cells
  Annals of the New York Academy of Sciences, 1993
• Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status
  British Journal of Cancer, 1993
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
  Histopathology, 1991